• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lung cancer screening: are we performing it satisfactorily?

作者信息

Minervini Fabrizio, Bertoglio Pietro, Kestenholz Peter B, Scarci Marco

机构信息

Division of Thoracic Surgery, Cantonal Hospital of Lucerne, Lucerne, Switzerland.

Division of Thoracic Surgery, IRCSS Azienda Ospedaliero-Universitaria, Bologna, Italy.

出版信息

J Thorac Dis. 2023 Jun 30;15(6):2899-2901. doi: 10.21037/jtd-23-411. Epub 2023 May 31.

DOI:10.21037/jtd-23-411
PMID:37426153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10323571/
Abstract
摘要

相似文献

1
Lung cancer screening: are we performing it satisfactorily?肺癌筛查：我们做得令人满意吗？
J Thorac Dis. 2023 Jun 30;15(6):2899-2901. doi: 10.21037/jtd-23-411. Epub 2023 May 31.
2
Screening and staging for non-small cell lung cancer by serum laser Raman spectroscopy.基于血清激光拉曼光谱的非小细胞肺癌筛查和分期。
Spectrochim Acta A Mol Biomol Spectrosc. 2018 Aug 5;201:34-38. doi: 10.1016/j.saa.2018.04.002. Epub 2018 Apr 13.
3
Factors associated with human small aggressive non small cell lung cancer.与人类小细胞侵袭性非小细胞肺癌相关的因素。
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2082-9. doi: 10.1158/1055-9965.EPI-07-0251.
4
Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.血清miR-152、miR-148a、miR-148b和miR-21作为非小细胞肺癌筛查中的新型生物标志物。
Tumour Biol. 2015 Apr;36(4):3035-42. doi: 10.1007/s13277-014-2938-1. Epub 2014 Dec 14.
5
Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.循环肿瘤细胞簇是检测非小细胞肺癌的一种有潜力的生物标志物。
Lung Cancer. 2019 Aug;134:147-150. doi: 10.1016/j.lungcan.2019.06.016. Epub 2019 Jun 17.
6
Targeting Pokemon is a novel strategy to suppress cancer aggressiveness of non-small cell lung cancer: Identification of Pokemon as ideal target for developing anti-NSCLC drugs.靶向 Pokemon 是抑制非小细胞肺癌侵袭性的一种新策略：将 Pokemon 鉴定为开发抗 NSCLC 药物的理想靶点。
Arch Biochem Biophys. 2023 Jul 1;742:109637. doi: 10.1016/j.abb.2023.109637. Epub 2023 May 12.
7
Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.血清狐猴酪氨酸激酶-3：一种用于筛查原发性非小细胞肺癌和预测癌症进展的新型生物标志物。
Int J Clin Exp Pathol. 2015 Jan 1;8(1):629-35. eCollection 2015.
8
Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer.GWAS 和转录组学数据的综合分析揭示了非小细胞肺癌的关键基因。
Med Oncol. 2023 Aug 17;40(9):270. doi: 10.1007/s12032-023-02139-x.
9
LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.长链非编码 RNA NBR2 通过下调 TGF-β1 调节非小细胞癌患者的肿瘤干细胞特性并预测其生存。
Curr Pharm Biotechnol. 2023;24(8):1059-1069. doi: 10.2174/1389201023666220728143410.
10
Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.美国计算机断层扫描筛查与肺癌分期转移和生存的关联：准实验研究。
BMJ. 2022 Mar 30;376:e069008. doi: 10.1136/bmj-2021-069008.

本文引用的文献

1
Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic.提高放射肿瘤诊所头颈癌患者的肺癌筛查率。
J Thorac Dis. 2022 Dec;14(12):4633-4640. doi: 10.21037/jtd-22-787.
2
Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness.低剂量计算机断层扫描肺癌筛查：国家支出与成本效益。
Front Public Health. 2022 Sep 29;10:977550. doi: 10.3389/fpubh.2022.977550. eCollection 2022.
3
Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study.多原发癌及肺腺癌的病理学及临床特征：多中心研究。
Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1). doi: 10.1093/icvts/ivac047.
4
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.肺癌筛查：美国预防服务工作组推荐声明。
JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.肺癌筛查的获益与挑战：对数据的综述及实施纲要。
J Thorac Oncol. 2021 Jan;16(1):37-53. doi: 10.1016/j.jtho.2020.10.127. Epub 2020 Nov 12.
7
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
8
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.国家肺癌筛查试验中延长随访后的肺癌发病率和死亡率。
J Thorac Oncol. 2019 Oct;14(10):1732-1742. doi: 10.1016/j.jtho.2019.05.044. Epub 2019 Jun 28.
9
The epidemiology of lung cancer.肺癌的流行病学
Transl Lung Cancer Res. 2018 Jun;7(3):220-233. doi: 10.21037/tlcr.2018.05.06.
10
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.使用低剂量计算机断层扫描的肺癌筛查策略的成本效益分析：一项系统评价
Appl Health Econ Health Policy. 2016 Aug;14(4):409-418. doi: 10.1007/s40258-016-0226-5.